Abstract
Determining the activity of a regulatory T-cell population in vitro is often the first step in analyzing its function. To obtain reliable and reproducible results, it is critical to follow the protocol that is most applicable to your experimental question. We have outlined below a basic in vitro suppression assay as well as a variety of alternative/additional protocols that can be utilized alone or in combination as desired.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., and Sakaguchi, S. (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10, 1969–1980.
Thornton, A. M., and Shevach, E. M. (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188, 287–296.
Annacker, O., Pimenta-Araujo, R., Burlen-Defranoux, O., and Bandeira, A. (2001) On the ontogeny and physiology of regulatory T cells. Immunol Rev 182, 5–17.
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., and Powrie, F. (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190, 995–1004.
Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M., and Sacks, D. L. (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502–507.
Cavinato, R. A., Casiraghi, F., Azzollini, N., Mister, M., Pezzotta, A., Cassis, P., Cugini, D., Perico, N., Remuzzi, G., and Noris, M. (2007) Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion. Kidney Int 71, 1132–1141.
Kingsley, C. I., Karim, M., Bushell, A. R., and Wood, K. J. (2002) CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168, 1080–1086.
McGeachy, M. J., Stephens, L. A., and Anderton, S. M. (2005) Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 175, 3025–3032.
Read, S., Malmstrom, V., and Powrie, F. (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192, 295–302.
Collison, L. W., Pillai, M. R., Chaturvedi, V., and Vignali, D. A. (2009) Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 182, 6121–6128.
Szymczak-Workman, A. L., Workman, C. J., and Vignali, D. A. (2009) Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. J Immunol 182, 5188–5192.
Liu, H., Komai-Koma, M., Xu, D., and Liew, F. Y. (2006) Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA 103, 7048–7053.
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., and Schuler, G. (2001) Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193, 1303–1310.
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., and Enk, A. H. (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193, 1285–1294.
Baecher-Allan, C., Brown, J. A., Freeman, G. J., and Hafler, D. A. (2001) CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167, 1245–1253.
Baecher-Allan, C., and Hafler, D. A. (2004) Suppressor T cells in human diseases. J Exp Med 200, 273–276.
Baecher-Allan, C., Viglietta, V., and Hafler, D. A. (2004) Human CD4+CD25+ regulatory T cells. Semin Immunol 16, 89–98.
Vignali, D. A., Collison, L. W., and Workman, C. J. (2008) How regulatory T cells work. Nat Rev Immunol 8, 523–532.
Wichlan, D. G., Roddam, P. L., Eldridge, P., Handgretinger, R., and Riberdy, J. M. (2006) Efficient and reproducible large-scale isolation of human CD4+ CD25+ regulatory T cells with potent suppressor activity. J Immunol Methods 315, 27–36.
Acknowledgments
We wish to thank members of the Vignali lab for many discussions regarding these methods. We are particularly grateful to Andrea Szymczak-Workman (for advice on anti-CD3/CD28 bead conjugation), Creg Workman and Andrea Szymczak-Workman (set up of murine antigen specific suppression assays), Janice Riberdy (human suppression assay setup), and Sam Connell (CFSE labeling). LWC is supported by an Individual NIH NRSA (F32 AI072816). DAAV is supported by the National Institutes of Health (NIH) (AI39480, AI52199, AI072239), Juvenile Diabetes Research Foundation International (1-2004-141 [The Robert and Janice Compton Research Grant, In Honor of Elizabeth S. Compton] and 1-2006-847), a Cancer Center Support CORE grant (CA21765), and the American Lebanese Syrian Associated Charities (ALSAC).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Collison, L.W., Vignali, D.A.A. (2011). In Vitro Treg Suppression Assays. In: Kassiotis, G., Liston, A. (eds) Regulatory T Cells. Methods in Molecular Biology, vol 707. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61737-979-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-61737-979-6_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-978-9
Online ISBN: 978-1-61737-979-6
eBook Packages: Springer Protocols